Susquehanna International Group, LLP Immunovant, Inc. Call Options Transaction History

Susquehanna International Group, LLP

13 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 07, 2024	SELL	$30.27 - $43.79 $239,133 - $345,941	-7,900 Reduced 3.49%	218,600 $7.06 Million
Q4 2023 Feb 14, 2024	SELL	$31.31 - $44.19 $2.14 Million - $3.01 Million	-68,200 Reduced 23.14%	226,500 $9.54 Million
Q3 2023 Nov 14, 2023	BUY	$18.55 - $39.96 $2.48 Million - $5.33 Million	133,500 Added 82.82%	294,700 $11.3 Million
Q2 2023 Aug 11, 2023	BUY	$14.2 - $23.75 $631,900 - $1.06 Million	44,500 Added 38.13%	161,200 $3.06 Million
Q1 2023 May 16, 2023	BUY	$15.27 - $19.72 $175,605 - $226,780	11,500 Added 10.93%	116,700 $1.81 Million

Q4 2022 Feb 14, 2023	BUY	$6.59 - $17.75 $66,559 - $179,275	10,100 Added 10.62%	105,200 $1.87 Million
Q3 2022 Nov 14, 2022	SELL	$3.93 - $6.37 $76,242 - $123,578	-19,400 Reduced 16.94%	95,100 $531,000
Q2 2022 Aug 15, 2022	BUY	$3.38 - $5.65 $10,140 - $16,950	3,000 Added 2.69%	114,500 $447,000
Q1 2022 May 16, 2022	SELL	$5.06 - $8.77 $419,979 - $727,910	-83,000 Reduced 42.67%	111,500 $614,000
Q4 2021 Feb 14, 2022	SELL	$7.33 - $9.32 $1.76 Million - $2.24 Million	-240,600 Reduced 55.3%	194,500 $1.66 Million
Q3 2021 Nov 15, 2021	BUY	$7.01 - $11.37 $1.67 Million - $2.7 Million	237,700 Added 120.42%	435,100 $3.78 Million
Q2 2021 Aug 11, 2021	BUY	$9.4 - $16.85 $1.58 Million - $2.83 Million	168,000 Added 571.43%	197,400 $2.09 Million
Q1 2021 May 17, 2021	BUY	$13.08 - $49.6 $384,552 - $1.46 Million	29,400 New	29,400 $472,000

238

62.9M

1.46M

546K

Ticker IMVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,077,000
Market Cap $3.55B
Description
Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.